NCT00900302
- Conditions
- Anus Diseases, Anus Neoplasms, Biliary Tract Diseases, +77 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Clinical trial condition
Urologic Neoplasms
Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.
2,952 public trials
630 recruiting studies
Urologic Neoplasms trial results
NCT02150148
- Conditions
- Behavior, Breast Diseases, Breast Neoplasms, +50 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
NCT02452944
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
Not specified
NCT00334282
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- GSK Investigational Site Capital Federal, Buenos Aires, Argentina
- GSK Investigational Site Córdoba, Córdoba Province, Argentina
- GSK Investigational Site Rosario, Santa Fe Province, Argentina
- GSK Investigational Site Quilmes, Argentina
NCT01402089
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +31 more
- Locations
-
- Cantonal Hospital St.Gallen Sankt Gallen, Switzerland
NCT00397488
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Completed
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients
NCT01169584
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, Ewing's Sarcoma, +54 more
- Locations
-
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
- Texas Children's Hospital Houston, Texas, United States
NCT02427321
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
- Locations
-
Not specified
Completed
Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
NCT00324870
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Peninsula Oncology and Hematology PA Salisbury, Maryland, United States
- University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
NCT01390519
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Novartis Investigative Site Kristiansand, Norway
- Novartis Investigative Site Tromsø, Norway
- Novartis Investigative Site Trondheim, Norway